TXNIP and lung adenocarcinoma: Compared to cisplatin-sensitive cells, cisplatin-resistant cells exhibit downregulation of TXNIP mRNA mediated by UCA1, suggesting a role of UCA1 and TXNIP in contributing to cisplatin resistance in lung adenocarcinoma [113].